Contract Pharma Manufacturing Webinars
-
Delivering Commercial Success: Large-Scale API Production Services
3/1/2024
Watch to see how one company excels in overcoming the most challenging small molecule API synthesis obstacles to help propel your program to new heights, regardless of the batch size.
-
Don’t Fear CDMO Or Facility Change
2/15/2024
One of our most experienced outsourcing professionals pleads with Outsourced Pharma readers to make the changes necessary to bring about optimal outsourcing.
-
FTEs, Fees-For-Service, Or Time-And-Materials?
2/15/2024
All three of our expert panelists have opinions and suggestions for Outsourced Pharma readers when it comes to how to hire the skilled workforce at a CDMO.
-
Scope-Of-Work Strategies When Contracting With CDMOs
2/15/2024
Nils Olsson, Cerus, and Andrei Blasko, Clearview Pharma Solutions, discuss how to scope out your scope of work for outsourcing development activities.
-
Backup Plans: At The Same Contract Developer Or Elsewhere?
2/15/2024
Our panelists get into an important discussion of what backup plans should entail to derisk outsourcing, and being one’s own “project manager” plays a role in all cases.
-
What Could Possibly Go Wrong?
2/15/2024
Andrei Blasko has worked at Big Pharma (Pfizer, Novartis, etc.) and smaller companies. When outsourcing development, he advises always asking – and answering – a key question.
-
CDMO Selection: One Size Doesn’t Fit All
2/15/2024
Nils Olsson, Vice President, CMC and Bioanalytical, Cerus, provides some salient advice on selecting your CDMO
-
Two Tips For Your Outsourcing Consideration
2/15/2024
Outsourcing, says Andrei Blasko, President and CEO, Clearview Pharma Solutions, is all about incentives … and moving to the next CDMO when necessary.
-
The Initial Contract With A CDMO
2/15/2024
Our expert panelist talks us through the best practices to put together your initial contract with a CDMO for development work on a biologics program.
-
CDMOs More Willing To Please
2/15/2024
Drug development and manufacturing veteran Perry Calias starts off our Outsourced Pharma Live event with a very positive assessment.